| __timestamp | AstraZeneca PLC | Soleno Therapeutics, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 5579000000 | 2242216 |
| Thursday, January 1, 2015 | 5997000000 | 4536244 |
| Friday, January 1, 2016 | 5890000000 | 5184803 |
| Sunday, January 1, 2017 | 5757000000 | 3068742 |
| Monday, January 1, 2018 | 5932000000 | 7178000 |
| Tuesday, January 1, 2019 | 5958000000 | 16267000 |
| Wednesday, January 1, 2020 | 5991000000 | 23191000 |
| Friday, January 1, 2021 | 9736000000 | 21453000 |
| Saturday, January 1, 2022 | 9762000000 | 15265000 |
| Sunday, January 1, 2023 | 10935000000 | 25189000 |
| Monday, January 1, 2024 | 13583000000 |
Unleashing the power of data
In the ever-evolving pharmaceutical landscape, investment in research and development (R&D) is a key indicator of a company's commitment to innovation. Over the past decade, AstraZeneca PLC has consistently outpaced Soleno Therapeutics, Inc. in R&D spending. From 2014 to 2023, AstraZeneca's R&D expenses surged by nearly 96%, peaking at approximately $10.9 billion in 2023. In contrast, Soleno's investment, while growing, reached just over $25 million in the same year.
AstraZeneca's substantial R&D budget reflects its strategic focus on pioneering treatments and maintaining a competitive edge in the global market. Meanwhile, Soleno's more modest investment highlights the challenges smaller firms face in scaling their innovation efforts. This stark contrast underscores the diverse strategies within the pharmaceutical industry, where both giants and niche players strive to make impactful advancements.
Novo Nordisk A/S or AstraZeneca PLC: Who Invests More in Innovation?
Johnson & Johnson vs AstraZeneca PLC: Strategic Focus on R&D Spending
Research and Development Investment: AstraZeneca PLC vs Teva Pharmaceutical Industries Limited
Who Prioritizes Innovation? R&D Spending Compared for AstraZeneca PLC and Biogen Inc.
Analyzing R&D Budgets: AstraZeneca PLC vs BeiGene, Ltd.
Research and Development: Comparing Key Metrics for AstraZeneca PLC and Ascendis Pharma A/S
Analyzing R&D Budgets: Sanofi vs Soleno Therapeutics, Inc.
Who Prioritizes Innovation? R&D Spending Compared for Takeda Pharmaceutical Company Limited and Soleno Therapeutics, Inc.
Comparing Innovation Spending: Viking Therapeutics, Inc. and Soleno Therapeutics, Inc.
Research and Development Expenses Breakdown: MorphoSys AG vs Soleno Therapeutics, Inc.
Who Prioritizes Innovation? R&D Spending Compared for Soleno Therapeutics, Inc. and Wave Life Sciences Ltd.
Research and Development: Comparing Key Metrics for Soleno Therapeutics, Inc. and MiMedx Group, Inc.